Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
MB on Twitter
If a fail, gotta be disclosed within four days. That train has left the station many moons ago. $NWBO #GBM as an aside Brian Lane is top Counsel for $NWBO and is one of the top securities lawyer in the country. He used to work for the SEC. #DUMBMEDIA stop the … bullshit
But its good to know ex knows better lol
well one thing we all can I agree on. If NWBO would again not adhere to SEC rules about timely submitting 10k/Q, as they have in the past, then an uplisting will be out of sight for sure.
I think they will delay the 10K as much as they can in anticipation of TLD/Publication and March 31 is the last day available to submit 10K apart from the option to request an extension of the deadline for 10 working days
I don't think they want any unauthorized delays anymore in anticipation of uplisting.
thats right
there will be no 10Q for Q4, next will be the 10K for all of 2021 including Q4 and this will probably be submitted on March 31 like last year
The canceling by Bosch for the Glioblastoma Drug Development Summit and now the announcement of SOS of a pending new article (presuming he is in contact with NWBO management) signals to me that we are yet in for another wait before TLD + publication. I can not imagine it will be later than Q1.
Lol haha
One can always divorce and find a new wife (or husband) but try to find a new good barbar ai ai ai lol
ooh horrible I know that one too. They tell me you said Topline data in 2020, in June, Sept, Dec and now you say Jan, Q1. Come to think of it the world is filled with Exwannabees arrrgggg lol
Im not aware of any such bet but if there was one he lost and he paid for steaks its that simple.
Im incredible happy I never touted NWBO as an investment opportunity to anyone tbh
You are treated to steak dinner if they become millionaires on your tip and feed you complaints and whining every day when it looks sourer and heads south. And with NWBO that is a lot of days of crap and not worth any steak
lol people you recommended NWBO to are now your park bench neighbor and refuse to talk to you?
Joan Lappin's articles in the past did have an enormous impact on the SP taking it from 1.45 to over 1.80. That impact has probably subsided now since everyone knows it does not last and what she predicted came not into fruition in the timeframe she predicted it would.
its not very difficult to guess why this is taking so absurd long, SOS takes a good stab at it
https://smithonstocks.com/northwest-biotherapeutics-fda-statement-regarding-use-of-external-controls-in-clinical-trials-is-a-huge-positive/
exactly thanks Flex
I have not misused anyone's email give me a break.
Hey Flex and thank you good morning to you too
You are right its up to the registered author to delete an account with NREJM. My mistake
The NEJM Author Center provides an array of informational resources to help guide you through the manuscript submission, review, and publication process. Learn about:
Editorial policies
Rigorous editorial, peer, and statistical review processes
How to prepare new and revised manuscripts for submission
What to expect if NEJM publishes your manuscript, including promotion and generous author permissions for content reuse
thanks
Look,
I personally dont think that https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-018-1507-6
was offered to NEJM by Liau, Ashkan and Bosch before for the simple reason that NEJM is not particularly fond of publishing interim blinded trials.
Bosch only published 4 times before https://www.biomedcentral.com/search?query=author%23%22Marnix%20L.+Bosch%22 none of them were in NEJM
I cant rule out the account was created prior to submitting the DCVAX L article but I hardly doubt it. So there is no guarantee as with many many posts here as have your posts no guarantee.
Also, Dr Liau probably submitted the article. But the NEJM author-center offers the option to assign co-authors to work on the article together and after. I think that is what happened here.
with his NWBO email thus under an NWBO account?
Could be to submit what?
I suspect all three (Ashkin, LL, and Bosch) have an account and work on it simultaneously
I haven't gotten around that to do so, but here is the problem in that thesis. LL has submitted in NEJM before so that would not prove it's for the one we are all waiting for? with MB I don't have that problem
by all means go ahead
I wanted to find out if NWBO had indeed submitted a manuscript with NEJM for sure. Then I thought of a simple plan to determine this. I visited The NEJM Author Center where authors can register to submit manuscripts with NEJM which can be found here:
https://www.nejm.org/author-center/home
I have zero hopes of BLA already being submitted. Hell if anything I would over the moon happy with just TLD at this point.
I think this whole talk about BLA is silly as long as we have not seen TLD ( and a publication)
But yes it would be an incredible waste of time if NWBO had not worked on a BLA
that is also true.
NWBO would be a world-first where BLA submission would proceed TLD announcement
I think its highly unlikely but I hope Im wrong
yes I agree
I got the same reply
DD this is how I see it what happened
Scenario 1
1. We know that the conference presentation was never meant to be held prior to TLD + Publication so during the quiet time.
=> Bosch must have been receiving many emails from the conference months prior and right up till the conference. So the conference and his responsibility for his attendance must have been on his mind all that time. Therefore if he knew weeks before the start of the conference that TLD + Publication would take a long time he would have canceled weeks before.
2. On Monday, January 10 MB was made aware by either email or a phone call from the event manager that his time of appearance had been shifted for Jan 20 from 11..40 to 12.10.
you are probably right. Im going to do a bit more research and think this over
thanks for all your great research DD
One thing Im convinced about the conference was supposed to be after results had been disclosed. There is just no way NWBO will present anything in their quiet period. I think it was kinda not on MB's radar when he got the email Thursday, got reminded, and canceled.
MB is definitely a co-author as he was in May 2018.
That to me indicates and I'm speculation now I realize that, that they still have not a definite publication date. Could be peer-reviewing which I suspect could be the last details.. we don't know where they are .
mmmmmm
https://glioblastoma-drugdevelopment.com/virtual-event-faqs/#speaker